Researchers at the Johns Hopkins Kimmel Cancer Center have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

Here are the most important news items that investors need to start their trading day: ...

George Medicines appoints Amy Carroll as Senior Vice President of Medical AffairsLondon, UK, 3 February 2025 – George Medicines, a late-stage ...

The last two episodes of Silent Witness season 28 are set to air tonight and tomorrow (February 3 and 4) and will see Nikki ...

Explore the difference between the SCHD and ETG funds, how they work, and what to expect in the next few months.

More than two years after the public debut of ChatGPT, software companies still haven’t found a compelling way of charging ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against ...

Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...